Clinical characteristics (n=141)
| Characteristics | Total (n=141) |
| Age (years) | 60.64±9.70 |
| Male, n (%) | 109 (77.3) |
| BMI (Kg/m2) | 26.15±3.36 |
| Diabetes, n (%) | 47 (33.3) |
| Hypercholesterolemia, n (%) | 65 (46.1) |
| Hypertension, n (%) | 82 (58.2) |
| Stroke, n (%) | 9 (6.4) |
| Smoke, n (%) | 43 (30.5) |
| Systolic blood pressure, mm Hg | 128.69±15.54 |
| Diastolic blood pressure, mm Hg | 75.15±10.79 |
| Heart rate | 73.81±10.38 |
| Medication, n (%) | |
| Aspirin | 129 (91.5) |
| Statin | 137 (97.2) |
| ACEI/ARB | 45 (35.6) |
| SGLT2 inhibitors | 22 (16.7) |
| Nicorandil | 23 (16.3) |
| Admission lab results | |
| Low-density lipoprotein cholesterol (mmol/L) | 1.82±0.69 |
| hs Tnl (pg/ml) | 3.5 (2.5,5.8) |
| Brain natriuretic peptide (pg/ml) | 29.00 (14.75,48.25) |
| Blood glucose (mmol/L) | 5.52 (4.82,7.33) |
| HbA1c (%) | 6.25 (5.7,7.1) |
| ICA and FFR characteristics | |
| 1-vessel disease | 50 (35.5) |
| 2-vessel disease | 43 (30.5) |
| 3-vessel disease | 48 (34.0) |
| Number of patients with FFR ≤0.8 | 68 (48.2) |
| Number of vessels with FFR | 157 |
| Number of vessels with FFR ≤0.8 | 74 (47.1) |
| Left anterior descending artery with FFR | 97 (68.8) |
| Left circumflex artery with FFR | 25 (17.7) |
| Right coronary artery with FFR | 35 (24.8) |
| Interval between MCG and FFR | 2 (1,7) |
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index; FFR, fractional flow reserve; ICA, invasive coronary angiography; MCG, magnetocardiography; SGLT2, sodium-glucose transport protein 2.